Since in clinical practice, nuclear medicine physicians may sometimes encounter difficulty in interpreting suspicious PSMA uptake, the presented findings provide several predictors of true positive PCa detection in patients with BCR. The gene discussed is FOLH1; the disease is posterior cortical atrophy.